Skip to main content
. 2017;18(8):2255–2268. doi: 10.22034/APJCP.2017.18.8.2255

Table 4.

Effect of PLL on Tumor Weight, Percentage of Tumor Volume, Body Weight, Mean Survival Time (MST) and Percentage Increase Life Span (%ILS) on Sarcoma-180 Solid Tumor Bearing Mouse

Poly L-lysine 20 mg/kg b.w Poly L-lysine 40 mg/kg b.w Std drug 20 mg/kg. b.w Sarcoma-180 Control (2 x 106 cells/mouse)
Tumor weight (gm.) 8.1 ± 0.04* 4.32 ± 0.05* 3.4 ± 0.04* 17.23 ± 0.13*
% Tumor volume 82.39 ± 0.07* 82.75 ± 0.06* 75.68 ± 0.07* 0 ± 0
Body weight(gm.) 23.64 ± 0.54* 20.63 ± 0.71* 19.18 ± 0.13* 35.02 ± 0.56*
MST(days) 72.16 ± 0.15* 78.38 ± 0.28* 55.5 ± 0.34* 22.5 ± 0.27*
% ILS 131.09 ± 0.08 142.84 ± 0.82 146.68 ± 0.27 0 ± 0